Table 4.
Cerebrospinal fluid.
| Parameter | All patients (n = 21) | Survivors (n = 15) | Nonsurvivors (n = 6) |
|---|---|---|---|
| Leukocytes CSF (cells/µL) | 151 (±221) | 158 (±256) | 132 (±103) |
| Lactate CSF (mmol/L) | 3.6 (±1.1) | 3.5 (±0.9) | 4.0 (±1.6) |
| Protein CSF (mg/L) | 1074 (±734) | 1071 (±793) | 1081 (±627) |
| Albumin quotient CSF/serum | 18.7 (±15.0) | 18.9 (±15.1) | 18.3 (±16.3) |
| IgG synthesis CSF (no.) | 4 | 1 | 3 |
| IgA synthesis CSF (no.) | 1 | 0 | 1 |
| IgM synthesis CSF (no.) | 5 | 3 | 2 |
| CSF oligoclonal bands (no.) | 12 | 8 | 4 |
Baseline cerebrospinal fluid (CSF) results from patients infected with cryptococcal meningoencephalitis prior to therapy. Laboratory findings are presented by mean value and standard deviation.